✦ LIBER ✦

Safety and effect of open-label agalsidase alfa in treatment-naïve children with Fabry disease

✍ Scribed by Pano, Arian; Goker-Alpan, Ozlem; Longo, Nicola; McDonald, Marie; Shankar, Suma; Shen, Yinghua; Chang, Peter; Schiffmann, Raphael

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti-drug antibody findings of agalsidas

✍ Goker-Alpan, Ozlem; Nedd, Khan; Shankar, Suma 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 115 KB

HGT-REP-059 treatment protocol: effect a

✍ Goker-Alpan, Ozlem; Nedd, Khan; Shankar, Suma; Lien, Y. Howard; Weinreb, Neal; W 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 47 KB

An open-label, switchover trial to asses

✍ Richards, Sarah; Laney, Dawn; Pervaiz, Muhammad A.; Shankar, Suma 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Safety of agalsidase alfa in patients wi

✍ U Ramaswami; R Parini; C Kampmann; M Beck 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

Safety and Efficacy of Enzyme Replacemen

✍ J. Edmond Wraith; Anna Tylki-Szymanska; Nathalie Guffon; Y. Howard Lien; Michel 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 198 KB

Safety and efficacy of long-term velaglu

✍ Giraldo, Pilar; Zimran, Ari; Mehta, Atul; Hughes, Derralynn; Hangartner, Thomas 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 265 KB